4th Quarter - Report

CROSSROADS STRATEGIES, LLC for ALTRIA CLIENT SERVICES LLC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.3268/S.1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L.115-90); H.J.Res.124, Making further additional continuing appropriations for fiscal year 2018, and for other purposes; H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96); Issues related to tobacco products.

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1603 (115th), S. 1771 (115th), H.R. 3268 (115th), H.J.Res. 123 (115th), H.R. 1370 (115th), H.J.Res. 124 (115th), H.R. 3358 (115th)

Health Issues HCR

CDC's implementation of health care funding provisions of the Patient Protection and Affordable Care Act (P.L.111-148). H.R.1136, FDA Deeming Authority Clarification Act of 2017; all provisions of the bill.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1136 (115th)

Financial Institutions/Investments/Securities FIN

corporate governance issues

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

H.R.1, Tax Cuts and Jobs Act (P.L.115-97); issues related to comprehensive tax reform.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 1 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.